Frédéric Clément

3.1k citations

39 papers · 1.9k · h-index 21

Impact in

Virology top 5%
Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation

Papers in

Epidemiology 26
- Influenza Virus Research Studies 10
- Hepatitis B Virus Studies 7
Immunology 20
- Immune Response and Inflammation 6
- Immunotherapy and Immune Responses 6
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 5

Co-authors: Geert Leroux‐Roels (31 shared papers)Isabel Leroux‐Roels (8 shared papers)Mamadou Dramé (2 shared papers)Astrid Borkowski (2 shared papers)Jeanne‐Marie Devaster (1 shared paper)Thomas Vanwolleghem (1 shared paper)Philippe Moris (6 shared papers)Pierre Vandepapelière (4 shared papers)
Journals: Vaccine (5 papers)Frontiers in Immunology (5 papers)Human Vaccines & Immunotherapeutics (4 papers)Clinical and Vaccine Immunology (4 papers)Journal of Immunological Methods (3 papers)
Partner nations: Belgium United Kingdom United States

In The Last Decade

Frédéric Clément

38 papers receiving 1.9k citations

Peers

Countries citing papers authored by Frédéric Clément

Since Specialization

Citations

This map shows the geographic impact of Frédéric Clément's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Clément with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Clément more than expected).

Fields of papers citing papers by Frédéric Clément

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Clément. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Clément. The network helps show where Frédéric Clément may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Clément, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Clément Line = papers co-authored together Frédéric Clément links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial The Lancet ·Isabel Leroux‐Roels, Astrid Borkowski, Thomas Vanwolleghem, Mamadou Dramé, Frédéric Clément, Eliane Hons, Jeanne‐Marie Devaster, Geert Leroux‐Roels	2007	414
2	Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages Scientific Reports ·Jonas D. Van Belleghem, Frédéric Clément, Maya Merabishvili, Rob Lavigne, Mario Vaneechoutte	2017	180
3	Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers Vaccine ·Pierre Vandepapelière, Yves Horsmans, Philippe Moris, Marcelle Van Mechelen, Michel Janssens, Marguerite Koutsoukos, Pascale Van Belle, Frédéric Clément, Emmanuel Hanon, Martine Wettendorff, Nathalie Garçon, Geert Leroux‐Roels	2008	168
4	H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses Journal of Clinical Immunology ·Philippe Moris, Robbert van der Most, Isabel Leroux‐Roels, Frédéric Clément, Mamadou Dramé, Emmanuel Hanon, Geert Leroux‐Roels, Marcelle Van Mechelen	2010	123
5	Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial Vaccine ·Isabel Leroux‐Roels, Sheron Forgus, Fien De Boever, Frédéric Clément, Marie‐Ange Demoitié, Pascal Mettens, Philippe Moris, Edouard Ledent, Geert Leroux‐Roels, Opokua Ofori‐Anyinam	2012	123
6	A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults The Journal of Infectious Diseases ·Isabel Leroux‐Roels, Geert Leroux‐Roels, Frédéric Clément, Pierre Vandepapelière, Ventzislav Vassilev, Edouard Ledent, Thomas C. Heineman	2012	112
7	Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans Frontiers in Immunology ·Wivine Burny, Andrea Callegaro, Viviane Bechtold, Frédéric Clément, Sophie Delhaye, Laurence Fissette, Michel Janssens, Geert Leroux‐Roels, Arnaud Marchant, Robert A. van den Berg, Nathalie Garçon, Robbert van der Most, Arnaud M. Didierlaurent	2017	101
8	Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes PLoS ONE ·Geert Leroux‐Roels, Cathy Maes, Frédéric Clément, Frank van Engelenburg, Marieke van den Dobbelsteen, Michael Adler, Mario Amacker, Lucia Lopalco, Morgane Bomsel, Anick Chalifour, Sylvain Fleury	2013	59
9	Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems Vaccine ·Isabel Leroux‐Roels, Marguerite Koutsoukos, Frédéric Clément, Sophia Steyaert, Michel Janssens, Patricia Bourguignon, Kristen W. Cohen, Marcus Altfeld, Pierre Vandepapelière, Louise Pedneault, Lisa McNally, Geert Leroux‐Roels, Gérald Voss	2010	56
10	An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers Clinical Infectious Diseases ·Eva Van Braeckel, Patricia Bourguignon, Marguerite Koutsoukos, Frédéric Clément, Michel Janssens, Isabelle Carletti, Alix Collard, Marie‐Ange Demoitié, Gérald Voss, Geert Leroux‐Roels, Lisa McNally	2011	50
11	Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines Human Vaccines & Immunotherapeutics ·Geert Leroux‐Roels, Isabel Leroux‐Roels, Frédéric Clément, Opokua Ofori‐Anyinam, Marc Lievens, Erik Jongert, Philippe Moris, W. Ripley Ballou, Joe Cohen	2014	45
12	Effect on Cellular and Humoral Immune Responses of the AS03 Adjuvant System in an A/H1N1/2009 Influenza Virus Vaccine Administered to Adults during Two Randomized Controlled Trials Clinical and Vaccine Immunology ·François Roman, Frédéric Clément, Walthère Dewé, Karl Walravens, Cathy Maes, Julie Willekens, Fien De Boever, Emmanuel Hanon, Geert Leroux‐Roels	2011	44
13	Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02_ACandidate Tuberculosis Vaccine in Purified Protein Derivative-Negative Adults Clinical and Vaccine Immunology ·Isabel Leroux‐Roels, Geert Leroux‐Roels, Opokua Ofori‐Anyinam, Philippe Moris, Els De Kock, Frédéric Clément, Marie‐Claude Dubois, Marguerite Koutsoukos, Marie‐Ange Demoitié, Joe Cohen, W. Ripley Ballou	2010	40
14	Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59^®adjuvant Human Vaccines & Immunotherapeutics ·Giovanni Della Cioppa, Uwe Nicolay, Kelly Lindert, Geert Leroux‐Roels, Frédéric Clément, Flora Castellino, Grazia Galli, Nicola Groth, Giuseppe Del Giudice	2012	30
15	The role of cell-mediated immunity against influenza and its implications for vaccine evaluation Frontiers in Immunology ·Yorick Janssens, Jasper Joye, Gwenn Waerlop, Frédéric Clément, Geert Leroux‐Roels, Isabel Leroux‐Roels	2022	29
16	Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette–Guérin-Vaccinated Adults Frontiers in Immunology ·Robert A. van den Berg, Laurane De Mot, Geert Leroux‐Roels, Viviane Bechtold, Frédéric Clément, Margherita Coccia, Erik Jongert, Thomas G. Evans, Paul Gillard, Robbert van der Most	2018	28
17	Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum Malaria Journal ·Frédéric Clément, Vincent Dewar, Eva Van Braeckel, Isabelle Desombere, Marianne Dewerchin, Christine Swysen, Marie‐Ange Demoitié, Erik Jongert, Joe Cohen, Geert Leroux‐Roels, Pierre Cambron	2012	28
18	Polyfunctional CD4+ T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine Vaccine ·Eva Van Braeckel, Isabelle Desombere, Frédéric Clément, Linos Vandekerckhove, Chris Verhofstede, Dirk Vogelaers, Geert Leroux‐Roels	2013	26
19	A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration Human Vaccines & Immunotherapeutics ·Giovanni Della Cioppa, Uwe Nicolay, Kelly Lindert, Geert Leroux‐Roels, Frédéric Clément, Flora Castellino, Cristina Galli, Nicola Groth, Yotam Levin, Giuseppe Del Giudice	2014	26
20	Evaluation of a New Rapid Test for the Combined Detection of Hepatitis B Virus Surface Antigen and Hepatitis B Virus e Antigen Journal of Clinical Microbiology ·Frédéric Clément, Pieter Dewint, Geert Leroux‐Roels	2002	26

About Frédéric Clément

Frédéric Clément is a scholar working on Epidemiology, Immunology, Infectious Diseases, Virology and Molecular Biology, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (10 papers), HIV Research and Treatment (9 papers), Hepatitis B Virus Studies (7 papers), Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). The work is most often cited by research in Virology (207 citations), Immunology (840 citations), Infectious Diseases (649 citations), Epidemiology (1.1k citations) and Microbiology (94 citations). Frédéric Clément has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Geert Leroux‐Roels, Isabel Leroux‐Roels, Mamadou Dramé, Astrid Borkowski, Jeanne‐Marie Devaster, Thomas Vanwolleghem, Philippe Moris, Pierre Vandepapelière, Rob Lavigne and Jonas D. Van Belleghem. Their work appears in journals such as Vaccine, Frontiers in Immunology, Human Vaccines & Immunotherapeutics, Clinical and Vaccine Immunology and Journal of Immunological Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Frédéric Clément

Impact in

Papers in i

In The Last Decade

Frédéric Clément

Peers

Countries citing papers authored by Frédéric Clément

Fields of papers citing papers by Frédéric Clément

All Works

About Frédéric Clément

Explore authors with similar magnitude of impact

Papers in